Von Willebrand Factor and ADAMTS-13 Are Associated with the Severity of COVID-19 Disease
Coagulopathy in COVID-19 patients is presumably based on systemic hypercoagulation with the inflammatory response. As a result of endothelial dysfunction, tissue factor and von Willebrand factor (vWF) are released into the blood stream, which leads to prothrombinase activation. The vWF/ADAMTS-13 rat...
Main Authors: | Nataliya Dolgushina, Elena Gorodnova, Olga Beznoshenco, Andrey Romanov, Irina Menzhinskaya, Lyubov Krechetova, Gennady Sukhikh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/14/4006 |
Similar Items
-
Procoagulant Status and Fibrinolytic Activity in COVID-19 Patients during Illness and Convalescence
by: Olga S. Beznoshchenco, et al.
Published: (2023-12-01) -
PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES
by: Stefano Lancellotti, et al.
Published: (2013-09-01) -
The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer
by: Chanukya K. Colonne, et al.
Published: (2022-03-01) -
Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
by: Gurbey Ocak, et al.
Published: (2021-06-01) -
The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
by: Benjamin Reardon, et al.
Published: (2021-09-01)